ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.40 +0.27 (+6.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

ARS Pharmaceuticals (SPRY) Total Liabilities (2020 - 2026)

Updated

ARS Pharmaceuticals' Total Liabilities was $236.98 million in Q2 2026, up 95.6% from $121.15 million a year earlier and up 4.7% from the prior quarter.

Analysis

ARS Pharmaceuticals (SPRY) Total Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Total Liabilities at ARS Pharmaceuticals came in at $213.39 million, up 126.2% from FY2024.

  • Total Liabilities shows a five-year compound annual growth rate of -12.2% (FY2020 to FY2025).
  • In earlier years, Total Liabilities was $94.36 million in FY2024, $2.43 million in FY2023 (-71.6%), $8.55 million in FY2022 (-90.8%) and $92.72 million in FY2021 (-77.3%).
  • The Q2 2026 figure marks the highest quarterly Total Liabilities since Q3 2022.
  • Compared with a year earlier, Total Liabilities has increased for three straight quarters, with growth averaging 99.8% over the last four quarters.
  • The best year-over-year quarter for Total Liabilities over five years was Q1 2026 (growth of 130.1%); the worst was Q1 2023 (a decline of 97.1%).
  • Per Business Quant data, SPRY's Total Liabilities in the three quarters before Q2 2026 was $226.26 million (Q1 2026), $213.39 million (Q4 2025) and $225.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 ARS Pharmaceuticals 410.68 Mn 266.88 Mn 20.81 Mn 236.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 236.98 Mn
Mar 31, 2026 226.26 Mn
Dec 31, 2025 213.39 Mn
Sep 30, 2025 225.15 Mn
Jun 30, 2025 121.15 Mn
Mar 31, 2025 98.34 Mn
Dec 31, 2024 94.36 Mn
Sep 30, 2024 16.62 Mn
Jun 30, 2024 6.73 Mn
Mar 31, 2024 3.72 Mn
Dec 31, 2023 2.43 Mn
Sep 30, 2023 11.27 Mn
Jun 30, 2023 10.20 Mn
Mar 31, 2023 10.04 Mn
Dec 31, 2022 8.55 Mn
Sep 30, 2022 321.22 Mn
Jun 30, 2022 338.03 Mn
Mar 31, 2022 350.72 Mn
Dec 31, 2021 92.72 Mn
Sep 30, 2021 20.43 Mn
API Access

ARS Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=SPRY&period=max&api_key=YOUR_API_KEY